| Authors: |
Fürstenau M; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany., Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Robrecht S; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany., Rotbain EC; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Eurelings L; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Giza A; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany., von Tresckow J; Department of Hematology, Oncology and Palliative Care, Katholisches Klinikum Bochum, Ruhr University Bochum, Bochum, Germany., Zhang C; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany., Gregor M; Division of Hematology, Cantonal Hospital of Lucerne, Lucerne, Switzerland., Thornton P; Department of Haematology, Beaumont Hospital, Royal College of Surgeons in Ireland, Cancer Trials Ireland, Dublin, Ireland., Staber PB; Department of Internal Medicine 1 (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical School, Homburg, Germany., Tadmor T; Hematology Unit, Bnai-Zion Medical Center, and The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Lindström V; Comprehensive Cancer Center, Department of Hematology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland., Juliusson G; Department of Hematology, Skåne University Hospital, Lund, Sweden., Janssens A; Department of Oncology, Universitaire Ziekenhuizen Leuven, Leuven, Belgium., da Cunha-Bang C; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Schneider C; Division of Chronic Lymphocytic Leukemia, Department of Internal Medicine III, University of Ulm, Ulm, Germany., Herishanu Y; Faculty of Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel., O'Shea D; Department of Hematology, Cork University Hospital, Wilton, Ireland., Baumann M; Department of Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland., Widmer A; Department of Medical Oncology and Haematology, Universitätsspital Zürich, Zürich, Switzerland., Nösslinger T; 3rd Medical Department for Hematology and Oncology, Hanusch Krankenhaus, Vienna, Austria., Poulsen CB; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Frederiksen H; Department of Hematology, Odense University Hospital, Odense, Denmark., Lotfi K; Department of Hematology, Linköping University Hospital, Linköping, Sweden., Ranti J; Department of Hematology, Turku University Central Hospital, Turku, Finland., Enggaard L; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Velders G; Department of Hematology, Gelderse Vallei Hospital, Ede, The Netherlands., Vekemans MC; Department of Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium., de Heer K; Department of Internal Medicine, Flevoziekenhuis, Almere, The Netherlands., Snijders TF; Department of Hematology, Medisch Spectrum Twente, Enschede, The Netherlands., Siemes C; Department of Hematology, Deventer Hospital, Deventer, The Netherlands., Wendtner CM; Medizinische Klinik III, Ludwig-Maximilians-Universität, Munich, Germany., Knauf W; Centrum für Hämatologie und Onkologie Bethanien, Frankfurt am Main, Germany., Kroeber A; Schwerpunktpraxis und Tagesklinik für Hämatologie und Onkologie, Regensburg, Germany., Zahn MO; MVZ Onkologische Kooperation Harz, Goslar, Germany., Illmer T; Gemeinschaftspraxis Hämatologie-Onkologie, Dresden, Germany., Schöttker B; Hämatologisch-Onkologische Schwerpunktpraxis Würzburg, Würzburg, Germany., Simon F; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany., Fink A; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany., Fischer K; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany., D'Brot R; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany., Holmes E; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany., Kreuzer KA; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany., Ritgen M; Department of Internal Medicine II, University Medical Center Schleswig-Holstein, Kiel, Germany., Brüggemann M; Department of Internal Medicine II, University Medical Center Schleswig-Holstein, Kiel, Germany., Tausch E; Division of Chronic Lymphocytic Leukemia, Department of Internal Medicine III, University of Ulm, Ulm, Germany., Stilgenbauer S; Division of Chronic Lymphocytic Leukemia, Department of Internal Medicine III, University of Ulm, Ulm, Germany., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Hallek M; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany., Kater AP; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands., Eichhorst B; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany. |
